Ads
related to: parkinson's disease treatment l-dopa- HCP Instructions for Use
Visit to Access Downloadable Forms
to Help Your Patients Get Started.
- Important Safety Info
Read Important Safety, Dosing,
& Tolerability Information.
- Peer Perspectives
Hear Other Physicians' Experiences
Treating Parkinson's Off Time.
- Receive Updates
Sign Up to Stay Informed & Learn
More About Current Treatments.
- HCP Instructions for Use
brainable.com has been visited by 10K+ users in the past month
swissmedica.startstemcells.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Levodopa-induced dyskinesia (LID) is a form of dyskinesia associated with levodopa (l-DOPA), used to treat Parkinson's disease. It often involves hyperkinetic movements, including chorea, dystonia, and athetosis. [1] In the context of Parkinson's disease (PD), dyskinesia is often the result of long-term dopamine therapy.
Current pharmacological intervention consist on the administration of L-dopa, a dopamine precursor. The L-dopa therapy increases dopamine production of the remaining nigral neurons. [2] Other therapy is the deep brain electrical stimulation to modulate the overactivity of the subthalamic nucleus to the loss of dopamine signaling in the stratum. [3]
The first study reporting improvements in patients with Parkinson's disease resulting from treatment with L-dopa was published in 1968. [1] The result was soon confirmed by other investigators and has now become the standard treatment for Parkinsonian symptoms.
On Thursday, the FDA approved AbbVie Inc’s (NYSE:ABBV) Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor fluctuations ...
l-DOPA can be manufactured and in its pure form is sold as a drug with the INN Tooltip International Nonproprietary Name levodopa. Trade names include Sinemet, Pharmacopa, Atamet, and Stalevo. As a drug, it is used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia. l-DOPA has a counterpart with opposite chirality ...
In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief ...
Ads
related to: parkinson's disease treatment l-dopa